1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Irritable Bowel Syndrome Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome Medication Overall Market Size
2.1 Global Irritable Bowel Syndrome Medication Market Size: 2022 VS 2029
2.2 Global Irritable Bowel Syndrome Medication Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Irritable Bowel Syndrome Medication Players in Global Market
3.2 Top Global Irritable Bowel Syndrome Medication Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome Medication Revenue by Companies
3.4 Top 3 and Top 5 Irritable Bowel Syndrome Medication Companies in Global Market, by Revenue in 2022
3.5 Global Companies Irritable Bowel Syndrome Medication Product Type
3.6 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome Medication Players in Global Market
3.6.1 List of Global Tier 1 Irritable Bowel Syndrome Medication Companies
3.6.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Medication Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Irritable Bowel Syndrome Medication Market Size Markets, 2022 & 2029
4.1.2 Irritable Bowel Syndrome with Constipation
4.1.3 lrritable Bowel Syndrome with Diarrhea
4.1.4 lrritable Bowel Syndrome with alternating Constipationand Diarrhea
4.2 By Type – Global Irritable Bowel Syndrome Medication Revenue & Forecasts
4.2.1 By Type – Global Irritable Bowel Syndrome Medication Revenue, 2018-2023
4.2.2 By Type – Global Irritable Bowel Syndrome Medication Revenue, 2024-2029
4.2.3 By Type – Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Irritable Bowel Syndrome Medication Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Homecare Settings
5.2 By Application – Global Irritable Bowel Syndrome Medication Revenue & Forecasts
5.2.1 By Application – Global Irritable Bowel Syndrome Medication Revenue, 2018-2023
5.2.2 By Application – Global Irritable Bowel Syndrome Medication Revenue, 2024-2029
5.2.3 By Application – Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Irritable Bowel Syndrome Medication Market Size, 2022 & 2029
6.2 By Region – Global Irritable Bowel Syndrome Medication Revenue & Forecasts
6.2.1 By Region – Global Irritable Bowel Syndrome Medication Revenue, 2018-2023
6.2.2 By Region – Global Irritable Bowel Syndrome Medication Revenue, 2024-2029
6.2.3 By Region – Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Irritable Bowel Syndrome Medication Revenue, 2018-2029
6.3.2 US Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.3.3 Canada Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.3.4 Mexico Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Irritable Bowel Syndrome Medication Revenue, 2018-2029
6.4.2 Germany Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.4.3 France Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.4.4 U.K. Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.4.5 Italy Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.4.6 Russia Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.4.7 Nordic Countries Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.4.8 Benelux Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Irritable Bowel Syndrome Medication Revenue, 2018-2029
6.5.2 China Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.5.3 Japan Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.5.4 South Korea Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.5.5 Southeast Asia Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.5.6 India Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Irritable Bowel Syndrome Medication Revenue, 2018-2029
6.6.2 Brazil Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.6.3 Argentina Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Irritable Bowel Syndrome Medication Revenue, 2018-2029
6.7.2 Turkey Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.7.3 Israel Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.7.4 Saudi Arabia Irritable Bowel Syndrome Medication Market Size, 2018-2029
6.7.5 UAE Irritable Bowel Syndrome Medication Market Size, 2018-2029
7 Irritable Bowel Syndrome Medication Companies Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Irritable Bowel Syndrome Medication Major Product Offerings
7.1.4 Bausch Health Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.1.5 Bausch Health Key News & Latest Developments
7.2 Sucampo Pharmaceuticals
7.2.1 Sucampo Pharmaceuticals Company Summary
7.2.2 Sucampo Pharmaceuticals Business Overview
7.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Major Product Offerings
7.2.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.2.5 Sucampo Pharmaceuticals Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Irritable Bowel Syndrome Medication Major Product Offerings
7.3.4 Abbott Laboratories Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 Lexicon Pharmaceuticals
7.4.1 Lexicon Pharmaceuticals Company Summary
7.4.2 Lexicon Pharmaceuticals Business Overview
7.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Major Product Offerings
7.4.4 Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.4.5 Lexicon Pharmaceuticals Key News & Latest Developments
7.5 Salix Pharmaceuticals
7.5.1 Salix Pharmaceuticals Company Summary
7.5.2 Salix Pharmaceuticals Business Overview
7.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Medication Major Product Offerings
7.5.4 Salix Pharmaceuticals Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.5.5 Salix Pharmaceuticals Key News & Latest Developments
7.6 lronwood Pharmaceuticals
7.6.1 lronwood Pharmaceuticals Company Summary
7.6.2 lronwood Pharmaceuticals Business Overview
7.6.3 lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Major Product Offerings
7.6.4 lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.6.5 lronwood Pharmaceuticals Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Irritable Bowel Syndrome Medication Major Product Offerings
7.7.4 GlaxoSmithKline Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Allergan
7.8.1 Allergan Company Summary
7.8.2 Allergan Business Overview
7.8.3 Allergan Irritable Bowel Syndrome Medication Major Product Offerings
7.8.4 Allergan Irritable Bowel Syndrome Medication Revenue in Global Market (2018-2023)
7.8.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Irritable Bowel Syndrome Medication Market Opportunities & Trends in Global Market
Table 2. Irritable Bowel Syndrome Medication Market Drivers in Global Market
Table 3. Irritable Bowel Syndrome Medication Market Restraints in Global Market
Table 4. Key Players of Irritable Bowel Syndrome Medication in Global Market
Table 5. Top Irritable Bowel Syndrome Medication Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Irritable Bowel Syndrome Medication Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Irritable Bowel Syndrome Medication Revenue Share by Companies, 2018-2023
Table 8. Global Companies Irritable Bowel Syndrome Medication Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Medication Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Irritable Bowel Syndrome Medication Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Irritable Bowel Syndrome Medication Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Irritable Bowel Syndrome Medication Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Irritable Bowel Syndrome Medication Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Irritable Bowel Syndrome Medication Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Irritable Bowel Syndrome Medication Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2024-2029
Table 30. Bausch Health Company Summary
Table 31. Bausch Health Irritable Bowel Syndrome Medication Product Offerings
Table 32. Bausch Health Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 33. Bausch Health Key News & Latest Developments
Table 34. Sucampo Pharmaceuticals Company Summary
Table 35. Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Product Offerings
Table 36. Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 37. Sucampo Pharmaceuticals Key News & Latest Developments
Table 38. Abbott Laboratories Company Summary
Table 39. Abbott Laboratories Irritable Bowel Syndrome Medication Product Offerings
Table 40. Abbott Laboratories Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Laboratories Key News & Latest Developments
Table 42. Lexicon Pharmaceuticals Company Summary
Table 43. Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Product Offerings
Table 44. Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 45. Lexicon Pharmaceuticals Key News & Latest Developments
Table 46. Salix Pharmaceuticals Company Summary
Table 47. Salix Pharmaceuticals Irritable Bowel Syndrome Medication Product Offerings
Table 48. Salix Pharmaceuticals Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 49. Salix Pharmaceuticals Key News & Latest Developments
Table 50. lronwood Pharmaceuticals Company Summary
Table 51. lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Product Offerings
Table 52. lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 53. lronwood Pharmaceuticals Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Irritable Bowel Syndrome Medication Product Offerings
Table 56. GlaxoSmithKline Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Allergan Company Summary
Table 59. Allergan Irritable Bowel Syndrome Medication Product Offerings
Table 60. Allergan Irritable Bowel Syndrome Medication Revenue (US$, Mn) & (2018-2023)
Table 61. Allergan Key News & Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome Medication Segment by Type in 2022
Figure 2. Irritable Bowel Syndrome Medication Segment by Application in 2022
Figure 3. Global Irritable Bowel Syndrome Medication Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Irritable Bowel Syndrome Medication Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Irritable Bowel Syndrome Medication Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome Medication Revenue in 2022
Figure 8. By Type - Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 9. By Application - Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 10. By Type - Global Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 12. By Application - Global Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 14. By Region - Global Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 15. By Country - North America Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 16. US Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 20. Germany Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 21. France Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 28. China Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 32. India Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 34. Brazil Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Irritable Bowel Syndrome Medication Revenue Market Share, 2018-2029
Figure 37. Turkey Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Irritable Bowel Syndrome Medication Revenue, (US$, Mn), 2018-2029
Figure 41. Bausch Health Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Laboratories Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Salix Pharmaceuticals Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Allergan Irritable Bowel Syndrome Medication Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
